perifosine has been researched along with Cancer of Endometrium in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dietl, J; Dombrowski, Y; Engel, JB; Grunewald, TG; Häusler, S; Honig, A; Krockenberger, M; Rieger, L; Schönhals, T; Weidler, C; Wischhusen, J | 1 |
| Block, M; Emons, G; Fister, S; Gründker, C; Günthert, AR; Seeber, S | 1 |
2 other study(ies) available for perifosine and Cancer of Endometrium
| Article | Year |
|---|---|
Perifosine inhibits growth of human experimental endometrial cancers by blockade of AKT phosphorylation.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Line, Tumor; Cisplatin; Endometrial Neoplasms; Female; Humans; Phosphorylation; Phosphorylcholine; Proto-Oncogene Proteins c-akt | 2008 |
Antiproliferative effects of antiestrogens and inhibitors of growth factor receptor signaling on endometrial cancer cells.
Topics: Apoptosis; Aromatase; Cell Line, Tumor; Cell Proliferation; Endometrial Neoplasms; Estrogen Antagonists; Female; Humans; Phosphorylcholine; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Receptors, Estrogen; Receptors, G-Protein-Coupled; Receptors, Growth Factor; Signal Transduction; Tamoxifen | 2010 |